MedPath

Gelesis, Inc.

Gelesis, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
2006-02-01
Employees
101
Market Cap
-
Website
http://www.gelesis.com

Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes

Not Applicable
Completed
Conditions
Overweight
Obesity
Interventions
Device: Gelesis100
Device: placebo
First Posted Date
2014-12-04
Last Posted Date
2022-08-30
Lead Sponsor
Gelesis, Inc.
Target Recruit Count
436
Registration Number
NCT02307279
Locations
🇪🇸

Investigative Site, Pamplona, Spain

© Copyright 2025. All Rights Reserved by MedPath